Research provides reassurance about the safety of testosterone treatment
Treatment with testosterone (the primary male sex hormone) does not increase the risk of heart attack, stroke or other diseases of the heart and blood vessels (cardiovascular disease), research found. The treatment was safe when given for less than a year to men with low levels of testosterone ( 2 External 0 0 0 hypogonadism false https://www.nhs.uk/conditions/male-menopause/#:~:text=Hypogonadism%20is%20sometimes%20present%20from,the%20%22male%20menopause%22%20symptoms. false false%>). Longer term follow up is ongoing. Men with hypogonadism can experience loss of muscle mass, sexual problems, and reduced quality of life...
Source: Current Awareness Service for Health (CASH) - February 7, 2023 Category: Consumer Health News Source Type: news

Lack of Sleep Disrupts Body Clock, Hormones Lack of Sleep Disrupts Body Clock, Hormones
Reverse schedules can disrupt the body ' s circadian rhythm, particularly in night-shift workers. Dr Peter Liu shares insight into new research on shift workers, hypogonadism, and hormones.Endocrine Society (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - November 11, 2022 Category: Endocrinology Tags: Diabetes & Endocrinology Article Source Type: news

Standard Testosterone Threshold Not Accurate for Younger Men
WEDNESDAY, Nov. 9, 2022 -- Age-specific cutoff points for low testosterone among men aged 20 to 44 years are substantially higher than the standard cutoff point, according to a study published online Oct. 25 in The Journal of Urology. Alex Zhu,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 9, 2022 Category: Pharmaceuticals Source Type: news

Testosterone Tied to Sustained Weight Loss in Men With Hypogonadism and Obesity
(MedPage Today) -- SAN DIEGO -- Long-term testosterone therapy was associated with sustained reductions in weight for men with hypogonadism and class III obesity, a researcher reported. In registry data on 76 patients, those who opted to receive... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 4, 2022 Category: Endocrinology Source Type: news

Low Testosterone May Raise Risk of COVID Hospitalization Low Testosterone May Raise Risk of COVID Hospitalization
Men with lower levels of testosterone were at increased risk for severe COVID-19, but androgen therapy appeared to provide protection, a new study found.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - September 8, 2022 Category: Endocrinology Tags: Internal Medicine News Source Type: news

COVID-19 Hospitalization Risk Higher for Men With Hypogonadism
THURSDAY, Sept. 8, 2022 -- Men with hypogonadism are more likely to be hospitalized after COVID-19 infection than those with eugonadism, according to a study published online Sept. 2 in JAMA Network Open. Sandeep Dhindsa, M.D., from the St. Louis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 8, 2022 Category: Pharmaceuticals Source Type: news

Low Testosterone Levels Tied to More Severe COVID in Men
(Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - September 5, 2022 Category: Reproduction Medicine Tags: Endocrinology, Reproductive Medicine, News, Source Type: news

Low Testosterone Levels Tied to More Severe COVID in Men
MONDAY, Sept. 5, 2022 -- Men with low testosterone levels may be more likely to have more severe illness when infected with COVID-19, according to a new study. Treating men who have low testosterone with hormone therapy may reduce their risk of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 5, 2022 Category: General Medicine Source Type: news

Low Testosterone Linked to Hospitalization for COVID
(MedPage Today) -- Normal testosterone levels in men might be protective against severe COVID-19, a retrospective cohort study suggested. Among 723 men with a mean age of 55, those who had hypogonadism had a higher risk of hospitalization for... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 2, 2022 Category: Endocrinology Source Type: news

New Oral Testosterone OK'd; Jarlsberg for Osteoporosis; Menopausal Women Lighting Up
(MedPage Today) -- The FDA approved a new oral testosterone undecanoate (Kyzatrex), primarily absorbed via the lymphatic system, for men with hypogonadism, Marius Pharmaceuticals announced. The Women's Preventive Services Initiative released new... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - August 3, 2022 Category: Endocrinology Source Type: news

FDA Approves Kyzatrex (testosterone undecanoate) for the Treatment of Male Hypogonadism
RALEIGH, N.C., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company, today announced the approval of Kyzatrex (testosterone undecanoate) by the U.S. Food and Drug Administration (FDA). Kyzatrex is an oral... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 2, 2022 Category: Drugs & Pharmacology Source Type: news

Raleigh pharma earns FDA approval for low testosterone drug
A Raleigh drugmaker developing therapies for testosterone deficiency has secured its first approval from the FDA. Next up, international markets. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 2, 2022 Category: American Health Authors: Zac Ezzone Source Type: news

Bayer to sell men's health product Nebido ™ to Grünenthal
Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price totaling up to 500 million Euro. Nebido for the treatment of male hypogonadism (testosterone deficiency) is available in over 80 countries since 2004. In 2021, the product contributed sales of 117 million Euro to Bayer's overall sales of more than 44 billion Euro. (Source: World Pharma News)
Source: World Pharma News - July 18, 2022 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

When to Treat Low Testosterone in Diabetes and Obesity When to Treat Low Testosterone in Diabetes and Obesity
Obesity or diabetes alone does not constitute a reason for screening for testosterone deficiency. But clinicians should screen for the symptoms of this deficiency.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 15, 2022 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Mayo Clinic Minute: How low testosterone can affect men's health
Millions of men live with a testosterone deficiency. If left unchecked, this treatable condition may contribute to serious health problems like osteoporosis and lowered red blood cell production. During National Men's Health Week — June 13–19 — Dr. Gregory Broderick, a Mayo Clinic urologist, encourages men with symptoms of low testosterone to speak with their health care team. Watch: The Mayo Clinic Minute https://www.youtube.com/watch?v=zLjkjFfFC8Y Journalists: Broadcast-quality video pkg (1:07) is in the downloads at the end… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 16, 2022 Category: Databases & Libraries Source Type: news